Murepavadin Enhances the Killing Efficacy of Ciprofloxacin against <i>Pseudomonas aeruginosa</i> by Inhibiting Drug Efflux

<i>Pseudomonas aeruginosa</i> is a multidrug-resistant Gram-negative pathogen and one of the leading causes of ventilator-associated pneumonia and infections in patients with chronic obstructive pulmonary disease and cystic fibrosis. Murepavadin is a peptidomimetic that specifically targets outer-me...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Xiaoya Wei, Dandan Zhou, Congjuan Xu, Ping Chen, Shuiping Chen, Zhihui Cheng, Yongxin Jin, Shouguang Jin, Weihui Wu
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2024-08-01
Sarja:	Antibiotics
Aiheet:	murepavadin <i>Pseudomonas aeruginosa</i> ciprofloxacin
Linkit:	https://www.mdpi.com/2079-6382/13/9/810
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!